Jane Mayotte
Impact in
-
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
Papers in
-
- Molecular Biology Techniques and Applications 3
- Oncology 4
- HER2/EGFR in Cancer Research 3
- Cancer Treatment and Pharmacology 1
- Cytokine Signaling Pathways and Interactions 1
- Co-authors
- Anna Lokshin (3 shared papers)Wendong Lei (2 shared papers)Mikhael F. El‐Chami (2 shared papers)Kurt Stromberg (2 shared papers)Reece Holbrook (2 shared papers)M. Rizwan Sohail (2 shared papers)Laurence M. Epstein (1 shared paper)Mark L. Levitt (2 shared papers)
- Journals
- Archives of Pathology & Laboratory Medicine (2 papers)JNCI Journal of the National Cancer Institute (2 papers)Journal of Clinical Oncology (1 paper)Experimental Cell Research (1 paper)International Journal of Oncology (1 paper)
- Partner nations
- United StatesSpainIreland
In The Last Decade
Jane Mayotte
14 papers receiving 433 citations
Peers
Comparison fields: 5 of 77
- Oncology 158
- Cancer Research 70
- Cardiology and Cardiovascular Medicine 94
- Genetics 30
- Molecular Biology 159
Countries citing papers authored by Jane Mayotte
This map shows the geographic impact of Jane Mayotte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Mayotte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Mayotte more than expected).
Fields of papers citing papers by Jane Mayotte
This network shows the impact of papers produced by Jane Mayotte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Mayotte. The network helps show where Jane Mayotte may publish in the future.
Co-authors
The 25 scholars most cited alongside Jane Mayotte, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 95 | |
| 2 | 1995 | 54 | |
| 3 | Enhancement of chemosensitivity and programmed cell death by tyrosine kinase inhibitors correlates with EGFR expression in non-small cell lung cancer cells. | 1999 | 53 |
| 4 | Platelet-derived growth factor D: tumorigenicity in mice and dysregulated expression in human cancer. | 2002 | 50 |
| 5 | 2009 | 46 | |
| 6 | 2009 | 45 | |
| 7 | 2020 | 22 | |
| 8 | 1999 | 20 | |
| 9 | Early effects of retinoic acid on proliferation, differentiation and apoptosis in non-small cell lung cancer cell lines. | 2000 | 16 |
| 10 | 1998 | 14 | |
| 11 | 1994 | 12 | |
| 12 | 2018 | 10 | |
| 13 | 1994 | 8 | |
| 14 | 2009 | 1 |
About Jane Mayotte
Jane Mayotte is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Biophysics, having authored 14 papers that have together received 446 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (3 papers), Molecular Biology Techniques and Applications (3 papers), Cell Image Analysis Techniques (2 papers), Blood properties and coagulation (2 papers), Cardiac pacing and defibrillation studies (2 papers), Cancer Treatment and Pharmacology (1 paper), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper) and Cytokine Signaling Pathways and Interactions (1 paper). The work is most often cited by research in Oncology (158 citations), Cancer Research (70 citations), Cardiology and Cardiovascular Medicine (94 citations), Genetics (30 citations) and Molecular Biology (159 citations). Jane Mayotte has collaborated with scholars based in United States, Spain and Ireland. Frequent co-authors include Anna Lokshin, Wendong Lei, Mikhael F. El‐Chami, Kurt Stromberg, Reece Holbrook, M. Rizwan Sohail, Laurence M. Epstein, Mark L. Levitt, Mark Gustavson and Maciej P. Zerkowski. Their work appears in journals such as Archives of Pathology & Laboratory Medicine, JNCI Journal of the National Cancer Institute, Journal of Clinical Oncology, Experimental Cell Research and International Journal of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.